Jinling Pharmaceutical Hits 10% Limit‑Up as Innovation‑Pharma Rally Fuels 2026 Gains
Jinling Pharmaceutical soars 10% on 4 Nov, riding a sharp innovation‑pharma rally amid 52% Q3 earnings growth and a surge in licensing deals.
4 minutes to read
JINLING PHARMACEUTICAL